Compounded tirzepatide: who sells it, and who will tell you who makes it

In its favor

• Flat $149/month that stays the same across every dose level — no escalation surcharge as you titrate up
• Doctor-reviewed protocols filled by a 503A compounding pharmacy
• Included 1:1 support from nurses and registered dietitians
• Automatic refund if you are not approved for treatment

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — see our evidence guide
• Single-medication focus rather than a broad telehealth catalog

In its favor

• Tirzepatide is priced publicly, with the amount actually charged stated rather than only a monthly average
• A genuinely reduced first cycle at $179 for the first four weeks
• Runs a Spanish-language lander as well as the English site, which most of this field does not

Against it

• There is no monthly rung at all. The only cadence is $897 paid up front every twelve weeks, so the advertised 'per month' figure is arithmetic rather than a payment anyone makes
• A 12-week cycle is 4.33 charges a year, not 4 — a year costs more than four times the block
• The $179 first cycle is an intro rate; the standing block applies from the second cycle on
• Compounded tirzepatide is not an FDA-approved product and is not a generic of Mounjaro or Zepbound

In its favor

• Unusually broad compounded menu under one roof — injectable and sublingual tirzepatide plus semaglutide, with NAD+, sermorelin, and TRT alongside
• Sublingual tirzepatide drops at $199/month sit $150 BELOW its own injection, where the rest of the category charges the same or more for a needle-free route
• Names its operator (Lovely Meds, Inc.), its prescribing practice (Wasef Health, PC / Michael Wasef, MD) and its dispensing pharmacy (The Pharmacy Hub, Miami) — three disclosures most compounded sellers make none of
• 100% online with licensed-clinician review, discreet delivery, and clear upfront compounded/not-FDA disclaimers

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — quality depends on the partner pharmacy
• At $349/month the injection does not undercut brand Zepbound across the board — LillyDirect self-pay is $299 at 2.5 mg and $399 at 5 mg, so the compounded route costs MORE at the doses most people start on
• The advertised 'from $159/mo', 'from $199' and 'from $249' figures are all twelve-month rates charged in a single upfront payment of $1,908, $2,388 or $2,988
• Sublingual tirzepatide drops lack the robust absorption and efficacy evidence of injectables — the lower price is a signal about the format, not a discount on the same drug
• No published list of states served, and a separate storefront catalog publishes a third set of prices behind a checkout that is disabled

In its favor

• Established since 2019 and sizable (250k+ members), with obesity-medicine clinicians — a longer track record than most compounded-only startups
• Broad formulary including the real FDA-approved brand-name products (Zepbound and Mounjaro), not only compounded tirzepatide
• Behavioral coaching, app, and member community paired with the medication
• Insurance navigation plus HSA/FSA accepted, available in all 50 states

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Layered pricing — the cheapest compounded rate requires a 3–12 month prepay
• The brand-name pathway stacks a separate membership fee (about $39/month) on top of the medication
• Cost and coverage vary by state and plan, so there is no single flat monthly figure

In its favor

• Low compounded entry at $179/month with all doses included, so titrating up costs nothing extra
• Available in all 50 states — broader coverage than most compounded-only startups
• Offers a brand-name pathway (Ozempic) alongside compounded options
• LegitScript-certified, with HRT and menopause care under the same roof

Against it

• The $179 headline requires a YEARLY subscription — no month-to-month price is published anywhere on the site
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The $149 microdose tier is sub-therapeutic and should not be read as a cheap tirzepatide dose
• The brand-name Ozempic option is very expensive at $1,299, and the dispensing pharmacy is never named

In its favor

• Publishes its full four-tier price ladder openly, with the billed total next to each per-month figure — rare candour in this category
• Flat price at every dose, so titration never raises the bill
• One membership covers the visit, medication and free overnight shipping to all 50 states
• Buy-now-pay-later (Affirm / Klarna / Afterpay) available on the prepaid terms

Against it

• The $125 headline needs $1,500 paid up front; month-to-month is $235, more than CoreAge's flat $149
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Prepaying a year for a medication you may not tolerate carries real refund risk
• Injectable only — no oral or brand-name pathway

In its favor

• Transparent, published tiered pricing including microdose and a sema+tirz combination
• Dose-flat within each tier — no surcharge as you titrate up
• Included provider care and 6-month lab testing
• NAD+ available as an adjacent longevity offering

Against it

• Compounded only — no FDA-approved brand or oral tirzepatide pathway
• Higher entry price ($280/month standard tirzepatide) than CoreAge's flat $149
• States served are not published on the site
• The standard tier costs more than several rivals for the same molecule

In its favor

• Transparent, publicly listed pricing on the site — many compounded competitors hide the price behind a quiz
• Both semaglutide and tirzepatide (not single-drug), plus a broad menu — NAD+, microdosing, and an optional coaching/nutritionist/labs bundle
• Markets 50-state clinician access with no insurance required and HSA/FSA accepted

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound), and compounding availability can tighten as brand shortages resolve
• Mid-market pricing at $299/month — above the cheapest compounders (~$99–$150)
• No brand-name and no oral pathway — injectable only
• Thin independent footprint with few third-party reviews; the 50-state and efficacy claims are self-reported

In its favor

• Multiple tirzepatide formats — compounded injectable, oral, and microdosed — a rare combination in one program
• LegitScript-certified and HIPAA-compliant, with U.S. providers and licensed pharmacies
• Low published entry price on annual plans (from $99/month tirzepatide; from $49/month microdosed), with HSA/FSA accepted and free 48-hour shipping
• Broad catalog beyond GLP-1 (semaglutide, PT-141, intranasal NAD+, recovery peptides, HRT)

Against it

• Every formulation is compounded — not the FDA-approved branded product (Mounjaro / Zepbound)
• The lowest headline prices require a 6- to 12-month commitment; short plans run $145/$199/$399 for the first month
• Pricing is opaque outside the GLP-1 menu, and the list of states served is not published
• No named clinicians and thin third-party reviews

In its favor

• Rare oral/sublingual tirzepatide option in addition to injectable
• All-inclusive pricing with no separate membership fee
• Offers both tirzepatide and semaglutide molecules

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Pricing is company-stated and could not be independently verified on a live page
• Newer operator (2024) with an ambiguous footprint across multiple domains
• States served are not disclosed
• FDA issued the company a warning letter in September 2025 — read it on FDA's own site

In its favor

• LegitScript-certified (#50087439) — a genuine third-party trust signal most compounded providers lack
• Physician-supervised, with a licensed U.S. 503A compounding pharmacy
• Offers tirzepatide, semaglutide, and a rare oral GLP tablet alongside injectable
• Transparent monthly pricing with no insurance required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Several tiers are company-stated and could not be independently verified on a live public page
• Brand tiers are an expensive pass-through (~$1,299)
• Number of states served is not published

In its favor

• LegitScript-certified — a genuine third-party trust signal many compounded startups lack
• Offers a real brand-name Wegovy/Zepbound pathway alongside compounded tirzepatide, uncommon for a low-cost compounder
• Transparent compounded pricing from $199/month tirzepatide (compounded semaglutide from $149/month)
• Low-friction signup — often no labs and no separate video visit required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• No named medical director, and the low-friction model (often no labs or visit) means thinner clinical oversight
• The two pharmacies it names — Foothills and Promise — are disclosed only in the Terms and the HIPAA notice, and neither is classified as 503A or 503B anywhere on the site
• Injectable only — no oral tirzepatide pathway
• State availability is quiz-gated rather than published, and $199/month is above the cheapest flat compounders
• FDA issued the company a warning letter in September 2025 — read it on FDA's own site

In its favor

• Value-priced compounded tirzepatide bundles — $139/month on the 12-month plan (from $209 the first month), undercutting most mid-market compounders
• Transparent GLP-1 pricing shown publicly on the site, with compounded semaglutide also from $139/month
• Backed by the recognizable Bodybuilding.com brand and a broad menu (NAD+, sermorelin, ED, peptides) under one login
• Standard telehealth flow: online intake reviewed by an independent licensed provider, free until you are approved

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Brand-new operator (Dynamo Group LLC, launched ~April 2026) with a thin, mixed third-party review record
• Lowest prices require a large upfront prepay, and prescription products are final sale — no refunds for change of mind or results
• Pharmacy and provider network are not named on the consumer pages, and we could not verify a LegitScript certification

In its favor

• Four routes to the same molecule — injection, liquid drops and lozenges compounded, plus brand Zepbound if you want the FDA-approved product
• Unlimited follow-up appointments and health coaching included with membership
• A published 120-day weight-loss guarantee, which almost nothing else in this ranking offers
• GLP-1 treatment available in all 50 states

Against it

• At $299/month month-to-month it costs twice CoreAge's flat $149 for the same molecule; reaching $239 means committing to twelve months up front
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The advertised "as low as $239" is a twelve-month commitment rate — the month-to-month price is $299
• The dispensing compounding pharmacy is not publicly named

In its favor

• No membership or subscription fee, and free shipping
• Same-day approval with no video call required
• All 50 states, with the process available in Spanish as well as English
• Advertises price-matching on any medication, which few programs here offer

Against it

• No usable published price: nine conflicting 'starting at' figures from $119 to $250, none carrying a term or a billing cadence, and the real ladder only appears after a 29-question intake
• The lowest figures, $119 and $185, appear only beside a '$200 off' new-patient offer that Oak describes as $50 off the first month and $200 off three months — a package discount, not a monthly rate
• Oak's 'all doses are the same price' claim is unconfirmed — a separate reading of its checkout copy recorded each dose step costing roughly $50–$75 more
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Same-day approval with no video call means very little clinical contact before a prescription

In its favor

• Sublingual tirzepatide lozenges at the same price as the injection, so the needle is optional without paying a premium for it
• Free physician visit, free shipping and free follow-up care included in the price
• Subscriptions can be canceled, paused or delayed yourself with 48 hours' notice
• Every route and price is published on the product page rather than hidden behind an intake

Against it

• At $199/month it costs more than CoreAge's flat $149 for the same molecule
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Asynchronous by design — in many states you will never speak to the prescriber
• Not available in Arkansas
• FDA issued the company a warning letter in February 2026 — read it on FDA's own site

In its favor

• One flat price at every dose, published dose by dose from 2.5mg to 15mg
• LegitScript verified, with board-certified physician review and U.S. compounding pharmacies
• Refund of everything but a $39 visit fee if you are not prescribed — stated up front, not buried
• Free overnight shipping with injection supplies included, and an oral tirzepatide route if you want it

Against it

• At $399/month on a quarterly commitment it sits near the best options here's price range — well above CoreAge's flat $149
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Available in 40 states rather than nationwide, so check yours before starting
• Ships one vial every two months, a less flexible cadence than a monthly refill

In its favor

• Will prescribe brand-name Mounjaro when clinically appropriate — genuine FDA-approved tirzepatide, not only compounded
• Unlimited appointments, messaging and 24/7 access to a dedicated clinical team
• FSA and HSA eligible

Against it

• No GLP-1 price anywhere on the public site — it prices its longevity line openly but not the medication this page is about
• At $349/month it sits near the top of this ranking, roughly $100 above the compounded tirzepatide median
• Does not publish which states it serves
• No published cancellation or refund terms
• The weakest conversion record of any program in this ranking, which usually tracks with a rough purchase experience

In its favor

• Oral tirzepatide as well as injectable — one of very few programs here offering the molecule without a needle
• LegitScript certified and HIPAA compliant, with a real brand pathway (Ozempic, Rybelsus) beside the compounded line
• One platform if you also want hair, TRT, sexual health or NAD+ handled in the same place

Against it

• No tirzepatide-specific price at all — the advertised $199 is a shared weight-loss starting figure across molecules
• Per-dose pricing is quiz-gated, so you cannot model a titrated monthly cost before entering the intake
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• No named clinicians, founding year or parent company disclosed, so transparency on who is behind it is thin

In its favor

• Nothing is charged until a provider approves you, and the consult is free if you go ahead
• One inclusive price covering consult, medication, supplies, shipping and support
• LegitScript certified, and available in all 50 states
• Cancel or change plan at any time, stated in the funnel rather than buried in terms
• NAD+ injections offered alongside the GLP-1 line if you want both from one provider

Against it

• Every quoted figure is for the LOWEST dose — the funnel states higher doses may cost more, so $299 is a floor, not the price of a titrated dose
• No tirzepatide price is published anywhere on the public site; you must complete an intake to see it
• At $299–$399/month it is well above CoreAge's flat $149 for the same molecule
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• An $80 consultation fee applies if you are approved and then decide not to proceed

In its favor

• Names its 503A compounding pharmacies — Belmar, Strive, Epiq Scripts and Casa Pharma Rx — with a phone number and a domain for each, rather than referring vaguely to 'US-licensed pharmacies'
• LegitScript certified, with the certificate number published (#50405601) and the seal served from LegitScript's own CDN bound to rxspanmd.com
• Physician-founded and openly attributed, which is unusual in compounded telehealth
• A real brand-name pathway (Zepbound, Mounjaro, Wegovy, Ozempic) alongside the compounded tiers, so you are not forced into a copy
• Ships to all 50 states, with expedited shipping and 24/7 support included in the price
• Publishes the operating entity, RxSpan MD LLC, in its own terms of service

Against it

• At $329/month month-to-month the compounded injection is well above the cheapest programs here
• Brand-name pricing is high even by brand standards — Zepbound and Mounjaro $1,069, Ozempic $1,299, Wegovy $1,349
• The oral capsule tier costs more than the injection month-to-month while having no published evidence that it absorbs
• A multi-vertical practice (hair, sexual health, longevity) rather than a weight-management specialist
• Its own FAQ says there are 'no long-term commitments', yet the cheapest rates require a three-, six- or twelve-month plan

In its favor

• Four compounded formats on one menu — semaglutide and tirzepatide, injectable or oral dissolving tablet
• Board-certified obesity specialists conducting the virtual consultations
• Available in 49 states, broader than most compounded GLP-1 programs
• The per-product price is visible after one click into the quiz, before any personal information is entered
• 24/7 support with a dedicated phone line

Against it

• The oral dissolving tablet is priced the same as the injection despite no published evidence that it absorbs
• Not available in Louisiana
• No visible LegitScript certification or PCAB accreditation, and the pharmacy partner is not named
• No static pricing page — the price is shown only inside the quiz flow, and any consult or add-on fees beyond the medication price are not visible until further into it

In its favor

• Physician-prescribed, nationwide telehealth practice founded 2021, HQ Miami FL
• Discounted $149 first month before the standing $249/month rate takes over
• Broader catalog on one account if you also want semaglutide, sermorelin, NAD+ or TRT

Against it

• Price steps up from $149 to $249/month after the first month, billed quarterly as a single ~$747 charge
• Not available in at least seven states for tirzepatide specifically, including AL, AR, CA, ID, MI, NC and TX — a wider exclusion list than the marketing page's own AL/ID-only disclosure
• Customer reviews are mixed
• The compounding pharmacy and the prescribing clinicians are not publicly named

In its favor

• A once-daily compounded tirzepatide TABLET at the same price as the weekly injection — a route most providers here do not offer at all
• The consultation and free overnight shipping are included in the monthly price rather than billed separately
• Both compounded semaglutide and compounded tirzepatide, each with a microdose line
• The full term ladder is published as a plan selector before intake, so the commitment discount is at least visible
• Affirm financing, a 90-day money-back guarantee, unlimited provider messaging and cancel-anytime

Against it

• Every advertised 'from $299/month' is the twelve-month rate — month-to-month for the same tirzepatide is $399
• At $399/month month-to-month it is one of the more expensive compounded programs here
• Canceling inside a committed term can claw back the discount: SkinnyRx's own policy says discounts 'may be reversed or proportionally adjusted'
• The Wegovy® Pill and Foundayo™ (orforglipron) Pill are both listed 'Unavailable', so the branded oral options are advertised but not obtainable
• States served are not publicly disclosed and sit behind the signup intake
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound), and no brand pathway is sold
• FDA issued the company a warning letter in February 2026 — read it on FDA's own site

In its favor

• The operating legal entity is named (Dr. Hank, LLC), which most competitors will not disclose
• The full tier ladder is itemised with up-front totals shown, so the prepay maths can be checked
• Free shipping, free consultation and cancel-any-time terms stated up front
• No insurance required, and the price is published before any intake quiz

Against it

• Every advertised price is an annual-prepay rate: "From $240" means $2,883 up front, and the month-to-month figure is $349
• No page renders the month-to-month rate at all — you have to reach the tier selector to find it
• The funnel's "from $200" matches no tier in the company's own catalog
• States served are not listed publicly
• GLP-1 is one of several verticals rather than the platform's focus
• No money-back guarantee or refund window is disclosed